2-Amino-7-propargyl-7,8-dihydro-8-oxo-9- (beta-D-xylofuranosyl) purine
Selected Variant
HY-154283
Size: 1 Each
2-Amino-7-propargyl-7,8-dihydro-8-oxo-9- (beta-D-xylofuranosyl) purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. 2-Amino-7-propargyl-7,8-dihydro-8-oxo-9- (beta-D-xylofuranosyl) purine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Product Specifications
CAS Number
2389988-53-6
UNSPSC
12352005
Target
Nucleoside Antimetabolite/Analog
Type
Oligonucleotides
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/2-amino-7-propargyl-7-8-dihydro-8-oxo-9-beta-d-xylofuranosyl-purine.html
Solubility
10 mM in DMSO
Smiles
O=C1N(CC#C)C2=C(N=C(N)N=C2)N1[C@@H]3O[C@H](CO)[C@H](O)[C@H]3O
Molecular Formula
C13H15N5O5
Molecular Weight
321.29
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog